Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - large image1
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image1
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image2
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image3
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image4
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image5
Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price buy - image6

Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price

TDS

Unit Price: Get Latest Price
CAS No.:

2757831-08-4

Grade:

Food Grade

Content:

1%

Port:

hongkong

Brand:

.

Packaging:

box

Sample Available:

Yes

Price valid (until):

2025-06-27

Company Type:
Trader
Location:
Hongkong, China
Payment Terms:
TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance
Qualification:
Main Products:

Peptides

  • Product Details

  • Seller Information

  • Description


      Product Detail  


    Description


     

      Product Detail  

     


    Retatrutide (LY3437943) acetate is a triple agonist peptide for the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R).

    Retatrutide acetate inhibits human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643, and 0.775 nM, respectively. It exhibits activity on mouse GCGR, GIPR, and GLP-1R with EC50 values of 2.32, 0.191, and 0.794 nM, respectively.

    In vivo, Retatrutide (LY3437943) acetate engages with GCGR and enhances glucose tolerance in an ipGTT by acting through GIP or GLP-1 receptors. Activation via the glucagon receptor by Retatrutide acetate leads to significant weight reduction and increased energy expenditure. Retatrutide acetate can be utilized in research related to obesity.

    Items Specifications
    Items Specifications
    Product Name Retatrutide
    CAS NO. 2381089-83-2
    Appearance white powder
    Storage Cool Dry Place
    Research & Reference Note

    Factory Supply High Quality Pharmaceutical Grade Peptides Gdf-8/Myostatn/Mt2/Dsip/Hmp for Muscle Gaining with The Best Price is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Disclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

    Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals

    Certificates

    Basic Info
    Product Name:

    Myostatin inhibitor D-peptide

    Other Name:

    (2R)-6-amino-N-[(2R)-1-[[(2R)-1-[[(2R,3R)-1-[[(2R)-1-[[(1R)-2-[[(2R)-6-amino-1-[[(2R,3R)-1-[[(2R)-1-[[(2R)-1-[[(2R,3R)-1-[[(2R)-1-[[(2R)-1-amino-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-cyclohexyl-2-oxoethyl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]-2-[[(2R)-2-[[(2R)-2-[[(2R)-2-amino-4-methylpentanoyl]amino]-5-carbamimidamidopentanoyl]amino]-2-cyclohexylacetyl]amino]hexanamide;D-Leu-D-Arg-D-Chg-D-Lys-D-Arg-D-Trp-D-Ile-D-Arg-D-Chg-D-Lys-D-Ile-D-Trp-D-Arg-D-Ile-D-Tyr-D-Trp-NH2;MID-35;Myostatin inhibitor D-peptide;Myostatin-IN-1

    CAS No.:

    2757831-08-4

    Molecular Formula:

    C118H184N34O17

    Molecular Weight:

    2350.95

    Categories:

    Polypeptide

    Characteristics
    Density:

    1.40±0.1 g/cm3(Predicted)

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Peptides

    Location:

    Room 5003, 5th Floor, Yau Lee Centre, 45 Yuen Yuen Road, Kwun Tong, Hong Kong

    Payment Terms:

    TT against copy of documents,D/P,L/C,D/A,O/A,TT against B/L draft before shipment,100% TT in advance

    Total Annual Revenue:

    Less than $1 million

    Total Employees:

    5-10

    Year of Establishment:

    2024

  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.